There was a slight trend toward more drug resistance mutations in patients with HBV genotype B (65/106, 61.3%) over patients with HBV genotype C (37/62, 59.7%), although this difference was not statistically significant ( P =0.833).
← all excerpts
Genotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy.
1
—
—